Harmony Biosciences Holdings, I - stock earnings
HRMY Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 AfterMarket | 0.67 / 0.64 | - | 154.6 million / 158.5 million | - |
| July 30, 2024 BeforeMarket | - / - | 169.3 million | - / 174.1 million | 180.6 million |
HRMY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 38.3 million USD | 154.6 million USD |
| 2023Q4 | 26.6 million USD | 168.4 million USD |
| 2023Q3 | 38.5 million USD | 160.3 million USD |
| 2023Q2 | 34.3 million USD | 134.2 million USD |
| 2023Q1 | 29.5 million USD | 119.1 million USD |
| 2022Q4 | 48.5 million USD | 128.3 million USD |
| 2022Q3 | 87.9 million USD | 117.2 million USD |
| 2022Q2 | 23.5 million USD | 107.0 million USD |
| 2022Q1 | 21.5 million USD | 85.3 million USD |
| 2021Q4 | 22.7 million USD | 91.2 million USD |
| 2021Q3 | -9.6 million USD | 80.7 million USD |
| 2021Q2 | 14.1 million USD | 73.8 million USD |
| 2021Q1 | 7.4 million USD | 59.7 million USD |
| 2020Q4 | -206000 USD | 56.3 million USD |
| 2020Q3 | 1.9 million USD | 45.6 million USD |
| 2020Q2 | -27000 USD | 38.0 million USD |
| 2020Q1 | -38.6 million USD | 19.8 million USD |
| 2019Q4 | -36.4 million USD | 6.0 million USD |
| 2019Q3 | -31.9 million USD | ? USD |
| 2019Q2 | -20.6 million USD | ? USD |
| 2019Q1 | -63.0 million USD | ? USD |
HRMY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 128.9 million USD | 582.0 million USD |
| 2022 | 181.5 million USD | 437.9 million USD |
| 2021 | 34.6 million USD | 305.4 million USD |
| 2020 | -51.9 million USD | 159.7 million USD |
| 2019 | -158.1 million USD | 6.0 million USD |
| 2018 | -39.9 million USD | ? USD |
HRMY
Price: $31.57
52 week price:
Earnings Per Share: 2.13 USD
P/E Ratio: 13.71
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 87588
Market Capitalization: 1.7 billion